Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial.
Summary
In a multicenter double-blind RCT (n=370), AI-guided targeting of spatio-temporal dispersion areas in addition to PVI achieved higher 12-month AF freedom (88% vs 70%) than PVI alone after a single procedure, with similar safety but longer procedure times. Freedom from any atrial arrhythmia was not different, suggesting subsequent organized atrial tachycardias may arise.
Key Findings
- AI-guided tailored ablation plus PVI achieved 88% AF freedom at 12 months vs 70% with PVI alone (superiority; log-rank P<0.0001).
- No difference in freedom from any atrial arrhythmia after one ablation, implying subsequent organized atrial tachycardias.
- Safety outcomes were similar between arms, but procedure and ablation times were approximately doubled in the AI-tailored arm.
Clinical Implications
AI-guided dispersion mapping may be adopted as an adjunct to PVI for persistent AF in experienced centers, balancing improved AF freedom against longer procedures and planning for potential post-ablation atrial tachycardias.
Why It Matters
This trial provides high-level evidence that AI-guided substrate mapping can improve outcomes in persistent AF beyond standard PVI, potentially redefining ablation strategy.
Limitations
- Single-procedure 12-month follow-up; longer-term durability and repeat procedures not assessed
- Longer procedure times in AI arm and no difference in any atrial arrhythmia freedom
Future Directions
Evaluate long-term durability, impact on organized atrial tachycardias, cost-effectiveness, and generalizability across centers and operators; integration with other mapping modalities.
Study Information
- Study Type
- RCT
- Research Domain
- Treatment
- Evidence Level
- I - Multicenter double-blind randomized controlled trial with predefined endpoints
- Study Design
- OTHER